Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Genosco logo — Turning unseen possibility into reality through innovative s...

Genosco

Turning unseen possibility into reality through innovative science

Founded 2008 United States Billerica, United States 26 employees Biotechnology

General Information

Company Name Genosco
Founded Year 2008
Location United States Billerica, United States
Employees 26
Industries Biotechnology
Social

BounceWatch is an independent company data service, not affiliated with Genosco. To contact Genosco, visit genosco.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genosco compare?

A PDF of Genosco and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genosco soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genosco

Genosco is a clinical-stage biotech company founded in 2008, with the slogan "Turning unseen possibility into reality through innovative science." The company focuses on the discovery and development of novel small-molecule drugs for patients with unmet medical needs. Genosco's proprietary G-SMART™ platform enables the discovery and optimization of rare sequences in protein kinases, leading to the development of highly selective compounds. The company has a strong portfolio of multiple independent and partnered pipelines, with its most advanced pipeline, Lazertinib, currently undergoing a phase 3 global clinical trial by Janssen and available in Korea for patients with EGFRm+ non-small cell lung cancer. The team, consisting of scientists with deep expertise in medicinal chemistry, structural & computational drug discovery design, cell biology, pharmacology, and drug metabolism, works with a mission to enhance people's lives through innovative science. Genosco's innovative approach and robust research and discovery programs position it as a key player in the biotechnology industry. The company is headquartered in the United States. As of now, there is no publicly disclosed information about the last investment and the involved investors. With its focus on precision medicine and a commitment to improving healthcare, Genosco presents an exciting opportunity for investors looking to support groundbreaking advancements in biotechnology.

Business keywords: biotech, small-molecule drugs, clinical-stage, precision medicine, protein kinases, drug discovery, EGFRm+ non-small cell lung cancer, phase 3 clinical trial, Janssen partnership, medicinal chemistry, selective kinase inhibitors, structural biology, pharmacology, interdisciplinary team, innovative science

No funding data available for Genosco yet.

Genosco Alternatives & Competitors

View All Alternatives
Genosco vs
Nexo Therapeutics
Nexo Therapeutics United States

We’re driven to translate the most compelling and still undrugged targets in human biology into med...

Series A
19 employees
Biotechnology, Health and Wellness
Genosco vs
Synnovation Therapeutics
Synnovation Therapeutics United States

A precision oncology company focused on small molecule therapies optimized to target key driver mech...

Series A
52 employees
Biotechnology, Health Care
Genosco vs
Tyra Biosciences
Tyra Biosciences United States

TYRA is focused on developing next-generation precision medicines that target large opportunities in...

85 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Genosco

Turning unseen possibility into reality through innovative science
Genosco was founded in 2008.
Genosco is headquartered in Billerica, United States.
Genosco operates in Biotechnology. Its work centres on biotech, small-molecule drugs, clinical-stage and precision medicine.
Genosco has approximately 26 employees.
Top alternatives and competitors to Genosco include Nexo Therapeutics, Synnovation Therapeutics, Tyra Biosciences, Advenchen Laboratories, LLC, Septerna. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genosco and Nexo Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genosco, https://bouncewatch.com/company/genosco, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout